Month: October 2024

Distinct immune “signatures” in patients who develop adverse events while taking immunotherapy for cancer may help oncologists identify patients at

Alzheimer’s disease may damage the brain in two distinct phases, based on new research funded by the National Institutes of

Hormone-driven cancers, like those of the breast and prostate, often rely on a tricky-to-target protein called Forkhead box protein 1

Higher levels of HDL-C — known as the “good cholesterol” — have been shown to correlate with heightened risk for

Medicare could save up to 74% of the money lost from discarded Alzheimer’s drug lecanemab by the simple introduction of

Use of a lifesaving drug to reverse opioid drug overdoses is growing, but not fast enough. That’s according to new

Preeclampsia is a life-threatening pregnancy complication marked by persistent high blood pressure that is even more serious when it occurs

A protein that is involved in determining which enzymes cut or unwind DNA during the replication process has been identified

Attention deficit/hyperactivity disorder — also known as ADHD — is typically thought of as a childhood condition. But more adults

Researchers at Dana-Farber Cancer Institute have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven